Association of platelet-derived growth factor-D gene polymorphism with ischemic stroke in a Chinese caseg-control study

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 5, 2008, Pages 415-419

  Han, Sheng Hong ^a,b   Liu, Jian Ping ^a,b   Tan, Alai ^c   Peng, Ji ^d   Zhang, Ren Li ^b   Gao, Shi Tong ^b   Huang, Da Na ^b   Yu, Lei ^b   Wang, Chong Jian ^a   Cheng, Jin Quan ^b,e   Nie, Shao Fa ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Shenzhen bao'An Centers for Disease Control and Prevention   (China)

^c University of Texas Medical Branch School of Medicine   (United States)

^d Shenzhen Municipal Hospital of Infectious Diseases   (China)

^e NONE   (China)

Author keywords

Casecontrol study; Ischemic stroke; Platelet derived growth factor D; Polymorphism

Indexed keywords

PLATELET DERIVED GROWTH FACTOR D;

ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ANAMNESIS; ARTICLE; BLOOD; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CHINESE; CONTROL GROUP; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA EXTRACTION; DNA POLYMORPHISM; ETHNICITY; FAMILY HISTORY; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PLATELET DERIVED GROWTH FACTOR D GENE; POPULATION; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 67649544679     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283049650     Document Type: Article

References (21)

1. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004; 363:1925-1933.
2. Matarin M, Brown WM, Scholz S, Simon-Sanchez J, Fung HC, Hernandez D, et al. A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol 2007; 6:414-420.
3. Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc 2006; 81:1241- 1257.
4. LaRochelle WJ, Jeffers M, McDonald WF, Chillakuru RA, Giese NA, Lokker NA, et al. PDGF-D, a new protease-activated growth factor. Nat Cell Biol 2001; 3:517-521.
5. LaRochelle WJ, Jeffers M, Corvalan JR, Jia XC, Feng X, Vanegas S, et al. Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer. Cancer Res 2002; 62: 2468-2473.
6. Chen J, Han Y,LinC, Zhen Y,Song X,TengS, et al. PDGF-D contributes to neointimal hyperplasia in rat model of vessel injury. Biochem Biophys Res Commun 2005; 329:976-983.
7. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999; 79:1283-1316.
8. Uutela M, Wirzenius M, Paavonen K, Rajantie I, He Y, Karpanen T, et al. PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Blood 2004; 104:3198-3204.
9. KanazawaS, Miyake T, Kakinuma T, Tanemoto K,Tsunoda T, Kikuchi K. The expression of platelet-derived growth factor and connective tissue growth factor in different types of abdominal aortic aneurysms. J Cardiovasc Surg (Torino) 2005; 46:271-278.
10. Pontén A, Folestad EB, Pietras K, Eriksson U. Platelet-derived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice. Circ Res 2005; 97:1036- 1045.
11. Raines EW. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 2004; 15:237-254.
12. Lusis AJ. Atherosclerosis. Nature 2000; 407:233-241.
13. Ostendorf T, Rong S, Boor P, Wiedemann S, Kunter U, Haubold U, et al. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 2006; 17:1054- 1062.
14. Gulcher JR, Gretarsdottir S, Helgadottir A, Stefansson K. Genes contributing to risk for common forms of stroke. Trends Mol Med 2005; 11:217-224.
15. Colaizzo D, Fofi L, Tiscia G, Guglielmi R, Cocomazzi N, Prencipe M, et al. The COX-2 G/C -765 polymorphism may modulate the occurrence of cerebrovascular ischemia. Blood Coagul Fibrinolysis 2006; 17:93-96.
16. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol 2007; 6:456-464.
17. Tan NY, Midgley VC, Kavurma MM, Santiago FS, Luo X, Peden R, et al. Angiotensin II-inducible platelet-derived growth factor-D transcription requires specific Ser/Thr residues in the second zinc finger region of Sp1. Circ Res 2008; 102:e38-e51.
18. Liu MY, Eyries M, Zhang C, Santiago FS, Khachigian LM. Inducible platelet-derived growth factor D-chain expression by angiotensin II and hydrogen peroxide involves transcriptional regulation by Ets-1 and Sp1. Blood 2006; 107:2322-2329.
19. Li X, Pontén A, Aase K, Karlsson L, Abramsson A, Uutela M, et al. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2000; 2:302-309.
20. Bergsten E, Uutela M, Li X, Pietras K, Ostman A, Heldin CH, et al. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol 2001; 3:512-516.
21. Molander C, Hackzell A, Ohta M, Izumi H, Funa K. Sp1 is a key regulator of the PDGF β-receptor transcription. Mol Biol Rep 2001; 28:223-233.